BDTX
Black Diamond Therapeutics Inc
1.90$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Black Diamond Therapeutics Inc (BDTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -7.1 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.1 | -2.1 | -1.9 | -2.4 | -6.9 | -5.0 | -5.3 | -7.5 | -11 | -14 | -11 | -16 | -24 | -25 | -26 | -24 | -29 | -18 | -16 | -22 | -20 | -14 | -18 | -14 | -21 | -15 | -11 | -15 | 53 | -9.2 | -7.9 | -6.8 | -10 | -7.1 | -32 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.9 | 2.5 | 1.9 | 1.4 | 2.0 | 2.5 | 3.1 | 4.6 | 3.0 | 3.4 | 3.4 | 3.3 | 2.7 | 2.9 | 2.7 | 2.6 | 2.8 | 1.5 | 1.7 | 5.3 | 2.0 | 1.6 | 1.7 | 1.8 | 1.7 | 1.4 | 1.4 | 1.5 | 6.1 | |
| – | – | – | 0.1 | 0.1 | 2.0 | 2.0 | 2.5 | 1.9 | 1.1 | 1.6 | 5.4 | 3.1 | 5.6 | 4.1 | 4.4 | 4.3 | 4.1 | 3.4 | 3.7 | 2.7 | 2.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.5 | -0.5 | 0.4 | 0.6 | -3.2 | 1.8 | 2.0 | -0.2 | -1.1 | -0.1 | 4.8 | 1.4 | 1.7 | 3.6 | 4.5 | -2.7 | -7.5 | 0.7 | 1.6 | -4.7 | -2.8 | 1.3 | 1.2 | 3.9 | -4.6 | 0.2 | 2.5 | -0.8 | -5.3 | -0.8 | -1.7 | -1.0 | -3.1 | 3.9 | -1.8 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.8 | 1.5 | 0.3 | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15 | 15 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -280 | -280 | 4.6 | -6.6 | 3.5 | 48 | 36 | 43 | 17 | 20 | 15 | 2.3 | 25 | 17 | -38 | 12 | -14 | 0.7 | 2.2 | 28 | 8.5 | -59 | 8.6 | -2.9 | 20 | -3.1 | 22 | |
| – | – | 5.0 | 52 | – | – | 45 | 129 | 214 | – | – | – | 0.5 | 0.2 | 0.1 | – | – | – | – | 0.0 | 0.1 | – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | 5.0 | 47 | 0.0 | -0.1 | 44 | 83 | 214 | 0.3 | 0.3 | 0.8 | 0.5 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 72 | 0.0 | 4.1 | 21 | -0.3 | 0.3 | 0.0 | -0.1 | 0.1 | -0.2 | -0.2 | 0.2 | 0.0 | |
| -2.1 | -2.1 | 3.1 | 45 | -6.9 | -5.1 | 39 | 76 | 203 | -293 | -6.6 | -22 | -21 | 23 | 9.3 | 19 | -12 | 1.7 | -1.9 | -20 | 4.8 | 2.8 | 16 | -1.8 | -31 | 7.4 | -9.4 | 13 | 62 | -68 | 0.9 | -9.9 | 9.1 | -10 | -10.0 | |
| -2.1 | -2.1 | -1.9 | -2.4 | -6.9 | -5.0 | -5.3 | -7.5 | -11 | -14 | -11 | -16 | -24 | -26 | -28 | -24 | -29 | -18 | -16 | -22 | -20 | -14 | -18 | -14 | -21 | -15 | -11 | -15 | 53 | -9.2 | -7.9 | -6.8 | -10 | -7.1 | -32 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.